Hypoxia assessment using simultaneous multiparametric PET/MRI
Hypoxia assessment using simultaneous multiparametric PET/MRI
WEBINAR

Hypoxia assessment using simultaneous multiparametric PET/MRI

A presentation on simultaneous PET/MRI methods and challenges in the characterization of hypoxia-induced physiological differences between breast cancer subtypes.

Webinar Overview

Hypoxia occurs due to inadequate oxygen supply and greatly influences solid tumor development and resistance to treatment. The tumor microenvironment can influence how aggressive a tumor is and correlate with underlying treatment resistance. Microenvironment biomarkers like tumor pH, hypoxia, and angiogenesis have been correlated with cancer aggression and patient outcomes. PET can play a critical role in the diagnosis, treatment orientation, and subsequent management of tumors as it can provide complementary information regarding tumor metabolic properties, particularly when performed simultaneously with advanced MRI techniques. 

Breast cancer is widely known for its high degree of intratumoral heterogeneity, induced by varying selective pressures from the hypoxic tumor microenvironment. In-depth characterization of hypoxia-induced physiological differences between breast cancer subtypes by simultaneous multiparametric PET/MRI would greatly benefit diagnosis and treatment planning in the clinic.

The purpose of this webinar is to discuss challenges in the establishment of MRI protocols, combining, e.g., a) dynamic contrast-enhanced (DCE) and intravoxel incoherent motion (IVIM) MRI for the assessment of intratumoral vascularization, b) hyperoxic blood oxygen level-dependent (BOLD) MRI for the quantification of oxygen delivery, and c) [18F]FMISO PET, highlighting hypoxic tumor subregions.

Finally, we will demonstrate how a combined analysis of simultaneous multiparametric PET/MRI-derived imaging parameters enables the identification of spatially defined and physiologically distinct intratumoral niches within the hypoxic tumor microenvironment. This characterization provides an existing novel perspective on breast cancer and opens up new targets for BC therapy.

September 26, 2024 | 04:00 PM CEST

What To Expect

In the context of a preclinical breast cancer model, a discussion on PET/MRI procedures and challenges to establish protocols that combine DCE and intravoxel incoherent motion for the assessment of intratumoral vascularization, hyperoxic BOLD for the quantification of oxygen delivery and [18F]FMISO PET.

Key Learning Topics

  • Simultaneous PET/MRI characterization of hypoxic breast cancer tumor microenvironment
  • Intratumoral vascularization
  • DCE & BOLD MRI & [18F]FMISO PET

Who should attend?

This webinar will be of interest to multiple profiles in the community of biomedical research especially those applying medical imaging techniques in their work. Clinicians, researchers, PhD students, and postdocs as well as laboratory technicians will find this webinar relevant.

Speaker

Silvester J. Bartsch

Department of Biomedical Imaging and Image-guided Therapy,

Medical University of Vienna, Vienna, Austria

Silvester J. Bartsch studied evolutionary biology at the Department of Theoretical Biology, University of Vienna, before he started his PhD-research project at the Department of Biomedical Imaging and Image-guided Therapy and the Medical University of Vienna. His current research aims at the characterization of niches within the hypoxic tumor microenvironment of breast cancer using simultaneous multiparametric PET/MR imaging. To this end, he combines [18F]FDG and [18F]FMISO PET with multiparametric MRI (diffusion-weighted MRI, blood oxygen level dependent MRI, glucose-enhanced CEST-MRI, dynamic contrast enhanced MRI) for the characterization the hypoxia-induced reprogramming of glucose metabolism, as well as the induction of angiogenesis, which are important hallmarks in breast cancer progression.

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

By ticking this box, I agree to receive, from time to time, emails from Bruker and its affiliates within the Bruker Group on upcoming events, webinars, our products and services, surveys and Bruker's corporate news.
I can unsubscribe at any time, by contacting Bruker or clicking on the opt-out link in the email if available. For more information on the processing of your personal data, please check Bruker’s Privacy Policy. 

By submitting this form I agree my personal data will be used to process my registration to the webinar. I have read and accepted the Bruker Website Privacy Notice (https://www.bruker.com/privacy-policy.html) and I agree to the Terms of Use (https://www.bruker.com/terms-of-use.html) of the Bruker website.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.